目的 制备葛根素聚乙二醇衍生化磷脂酰乙醇胺(PEG-PE)纳米胶束, 并研究其在急性心肌缺血模型小鼠体内的组织分布特点。方法 采用薄膜水化法制备葛根素PEG-PE纳米胶束, 昆明小鼠60只, 随机分成2组, 每组30只, 均尾静脉注射给予葛根素PEG-PE纳米胶束, 剂量为20 mgkg-1, 给药5 min后, 一组设为正常小鼠, 另一组小鼠结扎冠脉造成急性心肌缺血模型。分别于给药后30、60、90、120、150和180 min处死部分动物, 取心、肝、脾、肺、肾、脑等脏器, 测定2组小鼠组织中葛根素的浓度。结果 葛根素PEG-PE纳米胶束粒径约为25 nm, Zeta电位约为-3 mV, 载药量约为(5.8±1.3)%, 包封率约为(78.6±5.7)%;葛根素PEG-PE纳米胶束在正常小鼠脏器中AUC大小顺序为肝>肾>心>脾>肺>脑, 而在急性心肌缺血模型小鼠中的AUC大小顺序为肝≈心>肾>肺>脾>脑, 经计算模型小鼠心脏中的AUC为正常小鼠心脏中的1.9倍, 且存在显著性差异(P<0.05)。结论 葛根素PEG-PE纳米胶束具有良好的载药性能, 其在心肌梗死早期区域具有较好的心脏靶向性, 可以将药物蓄积于缺血心肌, 为该药的进一步开发研究提供重要的参考依据。
Abstract
OBJECTIVE To prepare puerarin-loaded PEG-PE nano-micelles and explore its tissue distribution in acute myocardial ischemia model mice. METHODS Puerarin-loaded PEG-PE nano-micelles were prepared by thin-film hydration method. Sixty KM mice were randomly divided into two groups (30 in each group). Both were given puerarin-loaded PEG-PE nano-micelles at a dose of 20 mgkg-1. After 5 min of medication, the mice in one group were treated with ligation of coronary artery to establish acute myocardial ischemia, and the other one group was taken as the control. The animals were executed at 30, 60, 90, 120, 150 and 180 min, then the heart, liver, spleen, lung, and kidney were extracted. The content of puerarin in the organ tissue was determined by HPLC. RESULTS The drug loading and drug encapsulation of puerarin-loaded PEG-PE nano-micelles were (5.8±1.3)% and (78.6±5.7)%, respectively, and the diameters and Zeta potential were 25 nm and -3 mV, respectively. The AUCs of tissue distribution of puerarin-loaded PEG-PE nano-micelles in the control group were in the sequence of liver>kidney>heart >spleen>lung>brain. While the AUCs of tissue distribution of PEGylated puerarin in acute myocardial ischemia model mice were in the sequence of liver≈heart>kidney>lung>spleen>brain. The AUCheart of puerarin-loaded PEG-PE nano-micelles in acute myocardial ischemia model mice was 1.9 times of that of the control mice (P<0.05). CONCLUSION Puerarin-loaded PEG-PE nano-micelles show excellent drug loading capabilities. It has good heart-targeting property in early myocardial infarction area and can accumulate in the ischemic myocardium. This study provides important information for further development of prepamiceion.
关键词
葛根素聚乙二醇衍生化磷脂酰乙醇胺纳米胶束 /
组织分布 /
急性心肌缺血 /
心脏靶向
{{custom_keyword}} /
Key words
puerarin-loaded PEG-PE nano-micelle /
tissue distribution /
acute myocardial ischemia /
heart-targeting
{{custom_keyword}} /
中图分类号：
R944
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] WU J, XIE J D, FU Q. Clinical observation of puerarin injection in treatment of 152 cases of coronary artery disease angina [J]. China Mod Med, 2013, 20(8): 87-88.
[2] GAO Q, PAN H Y, QIU S, et al. Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat heart[J]. Life Sci, 2006, 79(3): 217-224.
[3] YAO H, GAO Q, XIA Q. The role of mitochondrial K+ channels in the cardioprotection of puerarin against hypoxia/reoxygenation injury in rats[J]. Chin J Appl Physiol(中国应用生理学杂志), 2010, 26(4): 459-462.
[4] LIU X Y, LI J R, ZHANG L Y, et al.Optimization of synthetic process of PEGylated puerarin by orthogonal test with multi-index[J]. China Tradit Herb Drugs(中草药), 2011, 42(8): 1528-1531.
[5] LIU X Y, ZHI H Y, DU F, et al. A HPLC-UV method for the determination of puerarin in rat plasma after intravenous administration of PEGylated puerarin conjugate [J]. J Chromatogr B, 2010, 878(31): 3297-3302.
[6] MA G L, ZHAO S X, JING X, et al. Folate-conjugated Micelles Based on star-shaped PLGA-PEG-NH2 Copolymers as Novel Tumor-targeted Nanocarriers[J]. Chem T Chin Univ(高等学校化学学报), 2012, 33(8):1854-1859.
[7] FANG R H, LIANG W Q, ZHANG J J. Preparation of puerarin-loaded PEG-PE nano-micelle and its reducing hemolysis effect[J]. Chin J Mod Appl Pharm(中国现代应用药学), 2016, 33(9):1147-1152.
[8] HUANG J G, LESHUK T, GU F X. Emerging nanomaterials for targeting subcellular organelles[J]. Nano Today, 2011, 6(5):478-492.
[9] WANG J, WANG Y, LIANG W. Delivery of drugs to cell membranes by encapsulation in PEG-PE micelles[J]. J Controlled Release, 2012, 160(3):637-651.
[10] SUN G L, LIN X. Mechanisms and strategies for targeting drugs to myocardial ischemic regions [J]. Acta Pharm Sin(药学学报), 2010, 45(7):827-832.
[11] FORMIGA F R, GARBAYO E, DAZ-HERREZ P, et al. Biodegradation and heart retention of polymeric microparticles in a rat model of myocardial ischemia[J]. Eur J Pharm Biopharm, 2013, 85(3 Pt A): 665-672.
[12] SCOTT R C, CRABBE D, KRYNSKA B, et al. Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue[J]. Expert Opin Drug Deliv, 2008, 5(4): 459-470.
[13] LUKYANOV A N, HARTNER W C, TORCHILIN V P. Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits [J]. J Controlled Release, 2004, 94(1):187-193.
[14] MAEDA H, SAWA T, KONNO T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS [J]. J Controlled Release, 2001, 74(1-3):47-61.
[15] SUN G, LIN X, HONG Y, et al. PEGylation for drug delivery to ischemic myocardium: pharmacokinetics and cardiac distribution of poly(ethylene glycol)s in mice with normal and ischemic myocardium [J]. Eur J Pharm Sci, 2012, 46(5):545-552.
[16] LIN X, WANG Z J, WANG S, et al. Comparison of tissue distribution of a PEGylated Radix Ophiopogonis polysaccharide in mice with normal and ischemic myocardium [J]. Eur J Pharm Biopharm, 2011, 79(3):621-626.
[17] LUKYANOV A N, HARTNER W C, TORCHILIN V P. Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits[J]. J Controlled Release, 2004, 94(1): 187-193.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家自然科学基金资助项目(81673614);国家民委科研资助项目(14XBZ013);西北民族大学中央高校基本科研业务费专项资金资助项目(31920130045)
{{custom_fund}}
PDF(1643 KB)
